Subconjunctival THC:YAG laser thermal sclerostomy.
Identifieur interne : 000781 ( PubMed/Checkpoint ); précédent : 000780; suivant : 000782Subconjunctival THC:YAG laser thermal sclerostomy.
Auteurs : H D Hoskins [États-Unis] ; A G Iwach ; A. Vassiliadis ; M V Drake ; D R HenningsSource :
- Ophthalmology [ 0161-6420 ] ; 1991.
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Glaucome.
- usage thérapeutique : Fluorouracil.
- Adulte, Adulte d'âge moyen, Conjonctive, Enfant, Femelle, Glaucome, Humains, Mâle, Pression intraoculaire, Résultat thérapeutique, Sclérostomie, Sujet âgé, Sujet âgé de 80 ans ou plus, Thérapie laser, Études de suivi.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Fluorouracil.
- drug therapy : Glaucoma.
- surgery : Conjunctiva, Glaucoma.
- Adult, Aged, Aged, 80 and over, Child, Female, Follow-Up Studies, Humans, Intraocular Pressure, Laser Therapy, Male, Middle Aged, Sclerostomy, Treatment Outcome.
Abstract
A THC:YAG laser (thulium, holmium, chromium-doped YAG crystal) was used to create thermal sclerostomies in 21 glaucomatous eyes of 19 patients. The laser is a long-pulsed (300 microsec), compact, self-contained, solid state laser operating in the near infrared (2.1 mu). A 1-mm conjunctival stab incision was made 12 mm away from the sclerostomy site to allow entry of a specially designed 22-gauge (712 mu) optic probe that delivers energy at a right angle to the long axis of the fiber. Probe insertion produced minimal disturbance of the conjunctiva. Pulse energies of 80 mJ to 120 mJ were used with a repetition rate of 5 pulses/second. Total energy levels to produce full-thickness sclerostomies ranged from 1.4 to 4.8 J. Subconjunctival 5-fluorouracil injections were administered in 15 eyes. At 3 months the mean intraocular pressure of successful cases (16) was 14 mmHg (range, 9 to 22 mmHg). Of successful cases, the mean intraocular pressure at 6 months was 13 mmHg (range, 2 to 22 mmHg). Five cases failed within the initial 3 months, and 3 additional cases failed by 6 months. The authors conclude that this full-thickness sclerostomy technique may simplify filtering surgery without anterior chamber instrumentation and with minimal conjunctival trauma.
PubMed: 1945315
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:1945315Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Subconjunctival THC:YAG laser thermal sclerostomy.</title><author><name sortKey="Hoskins, H D" sort="Hoskins, H D" uniqKey="Hoskins H" first="H D" last="Hoskins">H D Hoskins</name><affiliation wicri:level="2"><nlm:affiliation>Foundation for Glaucoma Research, San Francisco, CA 94102.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Foundation for Glaucoma Research, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Iwach, A G" sort="Iwach, A G" uniqKey="Iwach A" first="A G" last="Iwach">A G Iwach</name></author><author><name sortKey="Vassiliadis, A" sort="Vassiliadis, A" uniqKey="Vassiliadis A" first="A" last="Vassiliadis">A. Vassiliadis</name></author><author><name sortKey="Drake, M V" sort="Drake, M V" uniqKey="Drake M" first="M V" last="Drake">M V Drake</name></author><author><name sortKey="Hennings, D R" sort="Hennings, D R" uniqKey="Hennings D" first="D R" last="Hennings">D R Hennings</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1991">1991</date><idno type="RBID">pubmed:1945315</idno><idno type="pmid">1945315</idno><idno type="wicri:Area/PubMed/Corpus">000805</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000805</idno><idno type="wicri:Area/PubMed/Curation">000805</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000805</idno><idno type="wicri:Area/PubMed/Checkpoint">000805</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000805</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Subconjunctival THC:YAG laser thermal sclerostomy.</title><author><name sortKey="Hoskins, H D" sort="Hoskins, H D" uniqKey="Hoskins H" first="H D" last="Hoskins">H D Hoskins</name><affiliation wicri:level="2"><nlm:affiliation>Foundation for Glaucoma Research, San Francisco, CA 94102.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Foundation for Glaucoma Research, San Francisco</wicri:cityArea></affiliation></author><author><name sortKey="Iwach, A G" sort="Iwach, A G" uniqKey="Iwach A" first="A G" last="Iwach">A G Iwach</name></author><author><name sortKey="Vassiliadis, A" sort="Vassiliadis, A" uniqKey="Vassiliadis A" first="A" last="Vassiliadis">A. Vassiliadis</name></author><author><name sortKey="Drake, M V" sort="Drake, M V" uniqKey="Drake M" first="M V" last="Drake">M V Drake</name></author><author><name sortKey="Hennings, D R" sort="Hennings, D R" uniqKey="Hennings D" first="D R" last="Hennings">D R Hennings</name></author></analytic><series><title level="j">Ophthalmology</title><idno type="ISSN">0161-6420</idno><imprint><date when="1991" type="published">1991</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Conjunctiva (surgery)</term><term>Female</term><term>Fluorouracil (therapeutic use)</term><term>Follow-Up Studies</term><term>Glaucoma (drug therapy)</term><term>Glaucoma (surgery)</term><term>Humans</term><term>Intraocular Pressure</term><term>Laser Therapy</term><term>Male</term><term>Middle Aged</term><term>Sclerostomy</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Conjonctive ()</term><term>Enfant</term><term>Femelle</term><term>Fluorouracil (usage thérapeutique)</term><term>Glaucome ()</term><term>Glaucome (traitement médicamenteux)</term><term>Humains</term><term>Mâle</term><term>Pression intraoculaire</term><term>Résultat thérapeutique</term><term>Sclérostomie</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Thérapie laser</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Fluorouracil</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Glaucoma</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Conjunctiva</term><term>Glaucoma</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Glaucome</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Fluorouracil</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Child</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Intraocular Pressure</term><term>Laser Therapy</term><term>Male</term><term>Middle Aged</term><term>Sclerostomy</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Conjonctive</term><term>Enfant</term><term>Femelle</term><term>Glaucome</term><term>Humains</term><term>Mâle</term><term>Pression intraoculaire</term><term>Résultat thérapeutique</term><term>Sclérostomie</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Thérapie laser</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A THC:YAG laser (thulium, holmium, chromium-doped YAG crystal) was used to create thermal sclerostomies in 21 glaucomatous eyes of 19 patients. The laser is a long-pulsed (300 microsec), compact, self-contained, solid state laser operating in the near infrared (2.1 mu). A 1-mm conjunctival stab incision was made 12 mm away from the sclerostomy site to allow entry of a specially designed 22-gauge (712 mu) optic probe that delivers energy at a right angle to the long axis of the fiber. Probe insertion produced minimal disturbance of the conjunctiva. Pulse energies of 80 mJ to 120 mJ were used with a repetition rate of 5 pulses/second. Total energy levels to produce full-thickness sclerostomies ranged from 1.4 to 4.8 J. Subconjunctival 5-fluorouracil injections were administered in 15 eyes. At 3 months the mean intraocular pressure of successful cases (16) was 14 mmHg (range, 9 to 22 mmHg). Of successful cases, the mean intraocular pressure at 6 months was 13 mmHg (range, 2 to 22 mmHg). Five cases failed within the initial 3 months, and 3 additional cases failed by 6 months. The authors conclude that this full-thickness sclerostomy technique may simplify filtering surgery without anterior chamber instrumentation and with minimal conjunctival trauma.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">1945315</PMID><DateCreated><Year>1991</Year><Month>12</Month><Day>09</Day></DateCreated><DateCompleted><Year>1991</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0161-6420</ISSN><JournalIssue CitedMedium="Print"><Volume>98</Volume><Issue>9</Issue><PubDate><Year>1991</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Ophthalmology</Title><ISOAbbreviation>Ophthalmology</ISOAbbreviation></Journal><ArticleTitle>Subconjunctival THC:YAG laser thermal sclerostomy.</ArticleTitle><Pagination><MedlinePgn>1394-9; discussion 1399-400</MedlinePgn></Pagination><Abstract><AbstractText>A THC:YAG laser (thulium, holmium, chromium-doped YAG crystal) was used to create thermal sclerostomies in 21 glaucomatous eyes of 19 patients. The laser is a long-pulsed (300 microsec), compact, self-contained, solid state laser operating in the near infrared (2.1 mu). A 1-mm conjunctival stab incision was made 12 mm away from the sclerostomy site to allow entry of a specially designed 22-gauge (712 mu) optic probe that delivers energy at a right angle to the long axis of the fiber. Probe insertion produced minimal disturbance of the conjunctiva. Pulse energies of 80 mJ to 120 mJ were used with a repetition rate of 5 pulses/second. Total energy levels to produce full-thickness sclerostomies ranged from 1.4 to 4.8 J. Subconjunctival 5-fluorouracil injections were administered in 15 eyes. At 3 months the mean intraocular pressure of successful cases (16) was 14 mmHg (range, 9 to 22 mmHg). Of successful cases, the mean intraocular pressure at 6 months was 13 mmHg (range, 2 to 22 mmHg). Five cases failed within the initial 3 months, and 3 additional cases failed by 6 months. The authors conclude that this full-thickness sclerostomy technique may simplify filtering surgery without anterior chamber instrumentation and with minimal conjunctival trauma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoskins</LastName><ForeName>H D</ForeName><Initials>HD</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Foundation for Glaucoma Research, San Francisco, CA 94102.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwach</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Vassiliadis</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Drake</LastName><ForeName>M V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Hennings</LastName><ForeName>D R</ForeName><Initials>DR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>UNITED STATES</Country><MedlineTA>Ophthalmology</MedlineTA><NlmUniqueID>7802443</NlmUniqueID><ISSNLinking>0161-6420</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003228">Conjunctiva</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005472">Fluorouracil</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005901">Glaucoma</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007429">Intraocular Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053685">Laser Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D012599">Sclerostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year><Month>9</Month><Day>11</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1991</Year><Month>9</Month><Day>11</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1945315</ArticleId><ArticleId IdType="pii">S0161-6420(91)32107-9</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><noCountry><name sortKey="Drake, M V" sort="Drake, M V" uniqKey="Drake M" first="M V" last="Drake">M V Drake</name><name sortKey="Hennings, D R" sort="Hennings, D R" uniqKey="Hennings D" first="D R" last="Hennings">D R Hennings</name><name sortKey="Iwach, A G" sort="Iwach, A G" uniqKey="Iwach A" first="A G" last="Iwach">A G Iwach</name><name sortKey="Vassiliadis, A" sort="Vassiliadis, A" uniqKey="Vassiliadis A" first="A" last="Vassiliadis">A. Vassiliadis</name></noCountry><country name="États-Unis"><region name="Californie"><name sortKey="Hoskins, H D" sort="Hoskins, H D" uniqKey="Hoskins H" first="H D" last="Hoskins">H D Hoskins</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000781 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000781 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:1945315
|texte= Subconjunctival THC:YAG laser thermal sclerostomy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:1945315" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |